Cargando…
What will it take to cure hepatitis B?
The current treatment of chronic HBV infection, pegylated interferon-α (pegIFNα) and nucleos(t)ide analog (NA), can suppress HBV replication, reverse liver inflammation and fibrosis and reduce the risks of cirrhosis, HCC, and HBV-related deaths, but relapse is common when the treatment is stopped be...
Autores principales: | Jeng, Wen-Juei, Lok, Anna S.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043561/ https://www.ncbi.nlm.nih.gov/pubmed/36972391 http://dx.doi.org/10.1097/HC9.0000000000000084 |
Ejemplares similares
-
Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
por: Suk‐Fong Lok, Anna
Publicado: (2018) -
Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
por: Teng, Wei, et al.
Publicado: (2021) -
Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA
por: Ghany, Marc G., et al.
Publicado: (2022) -
The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023) -
A global perspective on hepatitis B‐related single nucleotide polymorphisms and evolution during human migration
por: Tai, Dar‐In, et al.
Publicado: (2017)